The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

Drugs that both activate and block the GIP receptor reduce weight through different brain mechanisms, offering a new ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Citi launched its coverage of Structure Therapeutics with a Buy recommendation and a $60 per share target on Friday, citing ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Obesity alters how medications work, increasing the risk of underdosing, overdosing, and unknown interactions. Are package ...

The Italian Medicines Agency is ready to evaluate the reimbursement of new drugs against obesity, following the British model ...

A new expert review endorses GLP-1 RAs and other medications for sustainable weight loss in children with obesity and MASLD.

Navigating ineffective weight management treatment is a sensitive process that requires acknowledgement of bias from both ...

Amid new Canadian guidelines suggesting GLP-1 medication for obese kids and teens, dietitians say there are better ways ...